CMV Vaccine Study

Participants needed: This study is looking for generally healthy women who are 19 to 35 years of age.

Why are we doing this study: CMV is a common virus that can infect anyone. Most people don’t know they have CMV because it rarely causes symptoms. However, if you are pregnant or have a weakened immune system, CMV is cause for concern as it can cause serious disease. Newborns infected with CMV can develop permanent disabilities such as deafness and mental disability. There is no cure for CMV so researchers at the Vaccine Evaluation Center would like to evaluate the safety and effectiveness of a newer vaccine to protect women against CMV, as well as their babies if they become pregnant.

The study involves: Participants will be randomly assigned to receive either a vaccine to protect them against CMV or a placebo. There will be 8 visits to the study clinic that will include a physical exam, vaccinations, blood tests, questions about the participant’s health, and more. Total time commitment is 9 to 10 hours spread over the course of 18 months to 3 years, depending on when participants enter the study.

You will receive: Eligible participants will be reimbursed for travel/parking costs for each visit to the clinic and for their time.

To learn more and to see if you are eligible to participate, click here or please contact us.